Trihexyphenidyl and Cognition in Parkinson’s: Benefits, Risks, and Safer Use
Aug, 26 2025
If you’re weighing trihexyphenidyl (called benzhexol in Australia) for Parkinson’s tremor, you’re likely wrestling with a blunt trade-off: better tremor control versus fuzzier thinking. That tension is real. Anticholinergic drugs can quiet tremor, but they also block a brain system that supports memory, attention, and clear thinking-areas already vulnerable in Parkinson’s. The good news? You can reduce risk with the right patient selection, small doses, careful monitoring, and a willingness to switch gears if thinking slips.
What you’ll find here: a tight summary of how trihexyphenidyl affects cognition, who is most likely to feel it, how to use it safely (or avoid it), and what to ask your specialist. I’ve also added a quick checklist and answers to the questions people ask most in clinics and support groups.
- TL;DR
- Trihexyphenidyl can improve tremor in Parkinson’s, mostly in younger people with tremor-dominant symptoms, but it commonly worsens attention, memory, and processing speed.
- Risk climbs with age, baseline cognitive issues, hallucinations, and stacking other anticholinergic medicines. Most thinking problems improve after dose reduction or stopping.
- Use it only when tremor clearly limits life, after optimising levodopa and other options. Start low, go slow, and monitor thinking within 1-2 weeks of each dose change.
- Alternatives include levodopa optimisation, amantadine, clozapine for refractory tremor, and procedures like deep brain stimulation or focused ultrasound-each with trade-offs.
- In Australia, trihexyphenidyl is known as benzhexol. It carries a high Anticholinergic Cognitive Burden (ACB) score of 3 and is listed as potentially inappropriate for older adults in the Beers Criteria.
What trihexyphenidyl does to the brain in Parkinson’s
Trihexyphenidyl (benzhexol) is an anticholinergic. It blocks muscarinic acetylcholine receptors, especially M1, reducing “cholinergic” activity in parts of the brain that shape movement. In early Parkinson’s, tremor often reflects a dopamine-acetylcholine imbalance in motor circuits. Dampen acetylcholine and tremor can ease-particularly rest tremor and sometimes dystonic components. That’s the upside.
Here’s the catch: acetylcholine also underpins attention, working memory, learning, and visual processing. Parkinson’s already chips away at cholinergic pathways, especially as the disease advances. Adding an anticholinergic can push a wobbly system over the edge. People describe it as brain fog, trouble multitasking, word-finding hiccups, or slower thinking. Carers notice more repetitive questions, misplaced items, and missed steps in everyday tasks.
What does the evidence say? Randomised and controlled studies are small but consistent: anticholinergics help tremor modestly and impair cognition in measurable ways-slower processing speed, weaker working memory, and more confusion. The Movement Disorder Society’s evidence update tags anticholinergics as “possibly useful” for tremor, with a caution for older adults and anyone with cognitive problems (Fox et al., Movement Disorders, 2018; Seppi et al., Movement Disorders, 2019). In practical terms, they can work, but the window where they’re worth it is narrow.
Delirium is a bigger, louder version of the same biology. In hospital, anticholinergics are a known delirium trigger, especially after surgery or infections, when the brain is already stressed (Hshieh et al., CMAJ, 2015). Parkinson’s raises that baseline vulnerability. If someone becomes suddenly confused after a dose change or during an illness, anticholinergic load should be on the shortlist of culprits.
What about long-term brain health? Observational work links higher cumulative anticholinergic exposure to increased dementia risk. One of the most cited studies is the Adult Changes in Thought cohort (Gray et al., JAMA Internal Medicine, 2015), which found a dose-response relationship over years, with strong anticholinergics-like trihexyphenidyl-driving much of that signal. These studies can’t prove cause and effect, but they’re persuasive enough that geriatric and neurology guidelines urge caution, especially when safer options exist.
Who’s at most risk of cognitive harm?
- Age over 60-65, and especially over 70
- Any baseline cognitive impairment (low MoCA), history of hallucinations, REM sleep behaviour disorder, or Parkinson’s disease dementia
- Stacked anticholinergic drugs (e.g., amitriptyline, nortriptyline, paroxetine, quetiapine, clozapine, olanzapine, oxybutynin/solifenacin/darifenacin, cyclizine, promethazine)
- Brain stressors: infection, dehydration, recent surgery, sleep loss, pain
- Vision problems (blur), constipation, urinary retention-subtle signs of too much anticholinergic effect that often show up before obvious confusion
On the Anticholinergic Cognitive Burden scale, trihexyphenidyl scores a 3 (the highest tier), which is why it so often tips people into fogginess when combined with other meds (Boustani et al., Journal of the American Geriatrics Society, 2008). The American Geriatrics Society’s 2023 Beers Criteria list anticholinergics as potentially inappropriate in older adults because of these cognitive and fall risks.
Is the effect reversible? Usually. Many people feel clearer within days to weeks of reducing the dose or stopping. Memory scores often rebound, though not always fully if there are other contributors. That’s why it’s worth checking cognition after each dose change, not just waiting for the next annual review.
Quick Australian note: in clinics around Adelaide, benzhexol still pops up in younger, tremor-dominant cases. The theme I hear in our local support group is predictable: “It did help my tremor, but I couldn’t think straight for work.” When the priority is typing, drawing, or performing music without a shaking hand, some are willing to accept a small mental tax. For others, the cognitive toll ends the experiment fast.
How to use (or avoid) trihexyphenidyl safely: practical rules, monitoring, and alternatives
When might trihexyphenidyl be reasonable? Three common scenarios:
- Younger, tremor-dominant Parkinson’s with clear functional limits (e.g., a chef who cannot plate steadily) and no cognitive concerns.
- Levodopa helps bradykinesia and rigidity but leaves a disabling tremor, and other options are not accessible or acceptable right now.
- A short-term bridge while waiting for definitive therapy (e.g., deep brain stimulation work-up) with close monitoring.
Rules of thumb before starting:
- Exhaust simpler steps first: optimise levodopa timing and doses, address caffeine and anxiety that can amplify tremor, check sleep and pain.
- Screen cognition. A quick MoCA or similar, plus carer input, sets a baseline. If there’s mild impairment or hallucinations, think twice.
- Audit anticholinergic burden. Add up ACB scores across all meds. If it’s 3 or higher already, reduce other offenders first.
- Set a stop rule up front: “If thinking worsens by X (forgetting tasks, new confusion, work errors), we’ll pause and reassess.”
Dosing principles your specialist may use:
- Start low. Many begin at 0.5-1 mg once daily and increase by 0.5-1 mg every 5-7 days.
- Go slow. The typical effective range is 1-2 mg twice daily, sometimes three times daily. Higher doses increase side effects quickly.
- Time it to need. If tremor is worst in the morning, the larger portion may be taken earlier.
- Reassess benefit at each step. If tremor hasn’t improved meaningfully by a modest dose, pushing higher often buys side effects, not function.
Monitoring that actually works:
- Week 1-2 check-in after each dose change. Ask about attention, mistakes, misplacing items, word-finding, and new visual misperceptions.
- Carer observations matter. They often spot changes first.
- Watch bowel/bladder: new constipation, dry mouth, or urinary hesitancy are early signs to back down.
- Fall risk: dizziness, blurry vision, or daytime sleepiness are red flags.
When to taper or stop:
- Any new confusion, hallucinations, or delirium
- Worse memory or attention that affects daily tasks
- No meaningful tremor benefit after a careful trial
- Hospital admission, infection, or surgery (temporary pause often helps)
How to taper:
- Do not stop abruptly unless safety demands it (severe delirium). Otherwise, reduce by 0.5-1 mg every 3-7 days.
- Expect possible rebound: more tremor, sweating, nausea, anxiety. These usually settle. Keep fluids up and adjust other meds if needed.
- If you’re also on other anticholinergics, plan the sequence with your clinician to keep total burden dropping each week.
Alternatives and complements to consider (with honest trade-offs):
- Levodopa optimisation: Often the best tremor strategy remains better levodopa timing, fractionating doses, or adding a small controlled-release component for specific windows. Side effects: dyskinesia, nausea, low blood pressure.
- Amantadine: Can help tremor and dyskinesias. Watch for insomnia, ankle swelling, livedo reticularis, and cognitive effects at higher doses.
- Clozapine (low dose): Among the most effective for refractory tremor, but it needs regular blood monitoring for agranulocytosis and can cause sedation and drooling. Usually reserved for trickier cases under specialist care.
- Propranolol: Useful for action/kinetic tremor; limited for classic Parkinson’s rest tremor. Helpful when there’s a mixed picture with anxiety. Avoid if asthma or certain heart issues.
- MAO-B inhibitors or dopamine agonists: May help some tremor-dominant cases but bring their own cognitive and sleep-related side effects, especially agonists (impulse control disorders, sleep attacks).
- Deep brain stimulation (DBS): STN or GPi targets can dramatically reduce tremor and other motor symptoms in the right candidates. Selection is key; cognitive status matters.
- Focused ultrasound thalamotomy: Non-incisional, usually unilateral, effective for tremor. It’s not adjustable like DBS and has its own sensory and gait risks.
- Botulinum toxin: Great for dystonic tremor or focal hand issues. Too much weakens the hand, so dosing and placement matter.
- Non-drug strategies: Task-specific coaching with an occupational therapist, tremor-friendly cutlery and writing tools, wrist weights for selected tasks, and stress management. These don’t cloud thinking and can protect function while you sort out meds.
Interactions and special notes:
- Other anticholinergics add up fast. If someone is on oxybutynin for bladder or amitriptyline for sleep, swap to bladder training or mirabegron, and to non-anticholinergic sleep strategies or low-dose doxepin/mirtazapine if needed-under guidance.
- Cholinesterase inhibitors (rivastigmine, donepezil) pull the opposite way. Using them with anticholinergics is like driving with one foot on the brake and one on the accelerator. Sometimes there’s no choice, but it’s often counterproductive.
- Angle-closure glaucoma, significant urinary retention, and severe constipation are strong reasons to avoid anticholinergics.
Evidence pointers if you want to read more later: Fox et al., Movement Disorders (2018) and Seppi et al., Movement Disorders (2019) on motor symptom treatments; Bohnen & Albin, Lancet Neurology (2011) on cholinergic systems in Parkinson’s; Gray et al., JAMA Internal Medicine (2015) on cumulative anticholinergic use and dementia; American Geriatrics Society Beers Criteria (2023) on anticholinergics in older adults; and Boustani et al., Journal of the American Geriatrics Society (2008) on anticholinergic burden.
Tools, FAQs, and next steps you can use right now
A quick pre-start checklist (print this and take it to your appointment):
- My main goal is: reduce tremor enough to [cook/type/play guitar/hold a cup] without losing mental sharpness.
- Current tremor pattern: worst in morning / afternoon / evenings; rest vs action; how it affects tasks.
- Levodopa status: timing, current total daily dose, how long each dose lasts, “off” times.
- Recent cognition: any new forgetfulness, slowed thinking, word-finding issues, or visual misperceptions?
- Hallucinations history: none / mild (insight kept) / frequent (insight lost).
- Other anticholinergic meds on board (list them). Ask your clinician or pharmacist to tally your Anticholinergic Cognitive Burden score.
- Red flags I’ll watch for: confusion, worse memory, new falls, urinary retention, severe constipation, blurred vision.
- Stop rule we agree on: if X happens, we reduce or stop and call.
Simple decision cues:
- If you’re under 60, tremor-dominant, cognitively intact, and tremor is your main barrier: a cautious trial can be reasonable with a clear exit plan.
- If you’re over 70 or have any hallucinations or cognitive issues: steer away unless there’s an exceptional circumstance.
- If your ACB score is already 3 or higher: reduce other anticholinergics first or pursue non-anticholinergic options.
- If you’re headed for DBS work-up: consider a short, low-dose trial only if it meaningfully helps daily life while you wait.
Mini‑FAQ
- Will it cause permanent dementia? There’s no proof it directly causes dementia in the short term. Long-term, higher cumulative anticholinergic exposure is linked with greater dementia risk in observational studies (Gray et al., 2015). The safest approach is to keep exposure as low and brief as possible.
- Is brain fog reversible? Often yes. Many people feel clearer within days to weeks after reducing or stopping trihexyphenidyl. The sooner you act on early signs, the better.
- How quickly do side effects show up? Dry mouth and constipation can appear in days. Cognitive changes may emerge within 1-2 weeks after a dose increase, or suddenly during illness or hospitalisation.
- Can I take it with rivastigmine or donepezil? You can, but the drugs work against each other. If you need a cholinesterase inhibitor for thinking, anticholinergics are usually a poor fit.
- What about glaucoma or prostate issues? Anticholinergics can trigger angle-closure glaucoma and worsen urinary retention. Check with your ophthalmologist or urologist first.
- Is benzhexol the same drug? Yes. In Australia, trihexyphenidyl is often called benzhexol.
- What’s a typical dose? Many see if 1-2 mg twice daily helps. Higher doses raise risks quickly. Your specialist will individualise this.
- Can lifestyle changes help tremor? Stress management, paced breathing, and targeted occupational therapy can take the edge off tremor, especially during tasks that matter most to you.
Next steps for different scenarios:
- If you’re a younger worker with disabling tremor and clear thinking: bring a one-page goals list to your neurologist. Ask about a short, low-dose trial of trihexyphenidyl with a fixed review date. Set a stop rule if cognition dips.
- If you’re supporting an older family member who’s getting confused: gather the medication list (including sleep, bladder, allergy, and nausea meds). Ask the GP or pharmacist to calculate the Anticholinergic Cognitive Burden and map a deprescribing plan. Consider non-anticholinergic tremor options.
- If hospital delirium has occurred: request a discharge medication review focused on anticholinergic load. Ask the team to flag benzhexol as “avoid” in future admissions.
- If tremor is miserable despite good levodopa: ask for a referral to a movement disorders clinic to discuss DBS or focused ultrasound. These can transform tremor without the cognitive toll of anticholinergics in the right candidates.
- If constipation, urinary hesitancy, or blurry vision appear: treat them as early warning signs. Reduce dose and call your clinician rather than pushing through.
Pro tips from the clinic and the community:
- Pair every dose change with a simple cognitive check: a 2-3 minute word list, clock drawing, or a quick app-based test. Consistency beats complexity.
- Involve the person who spends the most time with you. They’ll spot subtle cognitive shifts before you do.
- Keep a tremor diary for a week before and after changes. A few lines per day beats fuzzy memory when you’re deciding whether a drug is helping.
- If you’re also on an SSRI for mood, ask whether paroxetine (anticholinergic) can be swapped to sertraline or escitalopram (lower anticholinergic activity) to free up cognitive headroom.
One last human note: I write this from Adelaide, where mornings start with Duke, our spotted Dalmatian, tugging me toward the park. I’ve heard the same story more than once on those walks: “The tremor was quieter, but my brain wasn’t mine.” That sentence is the heart of this decision. If a small tremor gain costs you your clarity, it isn’t a win. If a tiny dose buys you the steadiness to keep the job you love without muddling your thinking, it might be worth a cautious try-with eyes wide open and a short leash on the plan.
This article is general information for discussion with your clinician. It’s not personal medical advice. Work with your neurologist or GP to tailor a plan to your history, goals, and risks.
Selvi Vetrivel
August 30, 2025 AT 13:57So we’re just trading brain fog for steady hands? Cool. I’d rather forget where I put my keys than forget who I am. 🤷♀️
Nick Ness
August 31, 2025 AT 00:12The clinical evidence presented is robust and aligns with current Movement Disorder Society guidelines. Anticholinergic burden quantification via the ACB scale remains a critical tool in geriatric pharmacotherapy. I would emphasize that cognitive monitoring should be protocolized, not anecdotal.
Rahul danve
September 1, 2025 AT 18:48LOL so trihexyphenidyl is the new coffee? 🤭 "I need this to play guitar but my brain’s on vacation" - sounds like someone forgot they’re not a robot. Also, DBS? Bro, that’s just a fancy taser for your brain. 😎
Abbigael Wilson
September 3, 2025 AT 14:08How utterly pedestrian. The very notion of "brain fog" as a colloquialism betrays a fundamental lack of epistemological rigor. One must interrogate the phenomenological rupture caused by muscarinic antagonism-not merely lament "forgetting tasks." This isn’t a blog post, it’s a metaphysical crisis disguised as neurology.
Katie Mallett
September 3, 2025 AT 22:53Thank you for writing this with such care. I’ve seen too many patients get prescribed this without a single cognitive check-in. If you’re considering it, please, bring the checklist to your appointment. And if you’re a caregiver-your observations are medicine too.
Joyce Messias
September 5, 2025 AT 17:20Don’t let the fear of tremor steal your peace. You’re more than your shaking hand. If the drug makes you feel like a ghost in your own mind, it’s not worth it. You deserve clarity. Always.
Wendy Noellette
September 6, 2025 AT 07:22While the article is largely accurate, it should be noted that the term "benzhexol" is not exclusively an Australian nomenclature-it is also used in several Commonwealth nations, including South Africa and Malaysia. Precision matters.
Devon Harker
September 7, 2025 AT 16:47Of course you’re going to get dementia. You’re taking a drug that’s literally banned for seniors. What did you expect? That your brain would thank you? 🤡
Walter Baeck
September 8, 2025 AT 17:29I’ve been there. My dad was on this stuff for six months. Started at 1mg, went to 2mg, then 3mg because "it’s not working"-and suddenly he couldn’t remember his own birthday. We tapered slow, took three weeks, and he came back to us. Not 100%, but close enough. Don’t wait for disaster. Watch the small stuff-dry mouth, forgetting the kettle’s on, staring at the fridge like it’s a puzzle. Those are the first bells. Pull the plug before it rings too loud.
Austin Doughty
September 10, 2025 AT 16:59This article is a joke. You’re giving people permission to quit their meds? What about the people who actually need this? You think your brain is sacred? Mine’s been broken for 15 years. I’ll take foggy hands over stiff ones any day. Stop pretending this is a moral choice-it’s survival.
Oli Jones
September 11, 2025 AT 06:41There’s something deeply human in this tension-the tremor as a foreign voice in the body, the fog as the soul’s quiet retreat. We seek control, but in doing so, we risk losing the very mind that seeks it. Perhaps the real question isn’t whether to take it-but whether we’ve built a world that allows people to live with tremor without shame.
Clarisa Warren
September 11, 2025 AT 15:18why do people still use this drug? its literally on the beers list. i mean come on. also i think the author is too soft on dbt. its not a cure its a gamble. and why no mention of cannabis? i heard it helps tremor. maybe the pharma companies dont want you to know that.
Dean Pavlovic
September 13, 2025 AT 11:37Let’s be real. This isn’t medicine. It’s a corporate cover-up. Anticholinergics are cheap. DBS costs money. Who profits? Big Pharma. Who suffers? You. Your grandma. Your uncle who forgot his wedding anniversary. This isn’t science-it’s capitalism with a stethoscope.
Glory Finnegan
September 14, 2025 AT 00:24Brain fog? More like brain *fog*-as in, the kind you get when you’re trying to write a poem while someone yells at you in a language you don’t speak. 🤪
Jessica okie
September 15, 2025 AT 02:27Did you know the FDA knew this was dangerous in the 90s? They buried it. Now they’re selling it as "safe if you’re young." That’s a lie. They’re testing it on Parkinson’s patients to see how long it takes for the brain to melt. You’re part of the experiment.
Benjamin Mills
September 16, 2025 AT 19:58I just want to hold my granddaughter without shaking. I don’t care if I forget her name for a second. I’ll take it. You don’t get it. You’ve never held someone’s hand and felt them tremble because you couldn’t stop it. So shut up.
Craig Haskell
September 17, 2025 AT 12:41There’s a beautiful paradox here: the very neurotransmitter that enables movement-acetylcholine-is also the architect of memory, of self, of continuity. To dampen it is to risk dissolving the narrative of who we are. And yet, in the silence of a trembling hand, we beg for the quiet. The tragedy isn’t the drug-it’s that we’ve made people choose between dignity in motion and dignity in mind.
Ben Saejun
September 17, 2025 AT 21:30My mom took this for six months. She didn’t say anything. Just stopped reading the newspaper. Started rewatching the same three episodes of The West Wing. One day she looked at me and said, "Who are you again?" Not angry. Not scared. Just… gone. We stopped it. She got back. Slowly. But I’ll never forget the look. Don’t wait for that.
Visvesvaran Subramanian
September 18, 2025 AT 13:45Let the tremor be. Let the hand shake. The mind is the only thing no one can take from you. If you lose that, you lose everything. I’ve seen too many people trade their soul for a steady spoon.
Christy Devall
September 19, 2025 AT 04:05They call it "brain fog" like it’s just a bad day at the office. No. It’s the slow erasure of your inner monologue. The words you used to love-poetry, jokes, names-become ghosts. And they don’t come back. Ever. Not fully. This isn’t a trade-off. It’s a theft.